United Therapeutics Corporation
HealthcareNASDAQ:UTHR · NASDAQ Global Select
-$3.39 today
Vol 0.20M · Avg 0.54M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+91.28%
Period High
$596.76
Period Low
$274.70
Latest
$541.98
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Biogen Inc.
NASDAQ:BIIB
$29.59B
Illumina, Inc.
NASDAQ:ILMN
$24.39B
Royalty Pharma plc
NASDAQ:RPRX
$23.72B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.29B
Waters Corporation
NYSE:WAT
$23.16B
Quest Diagnostics Incorporated
NYSE:DGX
$22.45B
Incyte Corporation
NASDAQ:INCY
$21.79B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.12B
Genmab A/S
NASDAQ:GMAB
$15.38B
Tenet Healthcare Corporation
NYSE:THC
$15.26B
What is the latest UTHR filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does UTHR have?
Intrinsic Alpha currently shows 20 recent filings for UTHR.
Explore More
Continue the stock analysis
Jump to another research area for this company.